Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination

Information concerning the development of neutralizing antibodies and their duration will be critical to establishing herd immunity for COVID-19. We sought to evaluate SARS-CoV-2 spike protein receptor-binding domain (RBD)-specific antibodies, their duration, and capacity for SARS-CoV-2 neutralizati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedges, Jodi F., Thompson, Macy A., Snyder, Deann T., Robison, Amanda, Taylor, Matthew P., Jutila, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226813/
https://www.ncbi.nlm.nih.gov/pubmed/34199357
http://dx.doi.org/10.3390/vaccines9060587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226813/
https://www.ncbi.nlm.nih.gov/pubmed/34199357
http://dx.doi.org/10.3390/vaccines9060587

Ejemplares similares